Publications

Our faculty members publish numerous articles in scientific journals.  These articles appear below and may also be accessed on the webpage of each faculty member.

Picard F., Robin S., Lavielle M., Vaisse C.& Daudin J-J. (2005) A statistical approach for CGH microarray data analysis. BMC Bioinformatics 11;6(1):27.
Christian Vaisse, M.D., Ph.D
Mauvais-Jarvis F, Smith S.B., Le May C., Leal S.M., Gautier J.-F. Rajan A., Virally M., Kevorkian J.-P., Zhang S., Riveline J.-P, Charpentier G., Vexiau P., German M.S. & Vaisse C. (2004) PAX4 Gene variations Predispose to Ketosis prone Diabetes. Human Molecular Genetics (Vol 13, Issue24)
Christian Vaisse, M.D., Ph.D
Srinivasan S., Lubrano-Berthelier C., Govaerts C., Picard F., Santiago P, Conklin B., & Vaisse C. (2004) Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. Journal of Clinical Investigation 114:1158-1164.
Christian Vaisse, M.D., Ph.D
Xu, A.W. , Kaelin, C.B., Takeda, K., Akira, S., Schwartz, M.W., and Barsh, G.S. PI3K integrates the action of insulin and leptin on hypothalamic neurons. J. Clin. Invest. 2005, 115 (4): 951-958.
Allison Xu, Ph.D.
2002 Diabetes Prevention Trial – Type 1 Study Group[Gitelman SE—Study Group Member]. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med, 346: 1685-1691b.
Stephen E. Gitelman, M.D.
2002 Herold KC, Hagopian W, Auger J, Poumain-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan D, Xu D, Zivin R, Bluestone JA. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med, 346: 1692-1698.
Stephen E. Gitelman, M.D.
Stephen E. Gitelman, M.D.
2002 Greenspan LC, Gitelman SE, Mathias R. Increased incidence in post-transplant diabetes mellitus in children: a case-control analysis. Pediatric Nephrology, 17:1-5.
Stephen E. Gitelman, M.D.
2004 Conrad SC, Mastratatoro J, Gitelman SE. The use of a continuous glucose monitoring system in hypoglycemic disorders. J Pediatric Endocrinol Metab 17: 281-88.
Stephen E. Gitelman, M.D.
2004 Steele C., Hagopian, WA, Gitelman SE, Masharani U, Cavaghan M, Rother K, Donaldson, D, Harlan D, Bluestone J, Herold KC. Insulin secretion in type 1 diabetes. Diabetes 53: 426-33.
Stephen E. Gitelman, M.D.
2005 Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gitelman SE. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 28: 15-19.
Stephen E. Gitelman, M.D.
2005 Sapru A, Gitelman SE, Bhatia S, Dubin R, Flori H. Prevalence and characteristics of type 2 diabetes mellitus in 9-18 year-old children with diabetic ketoacidosis. J Pediatric Endocrinol Metab, In press.
Stephen E. Gitelman, M.D.
2005 Huang E, Feldman B, Geller D, Schwartz D, Gitelman SE. Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children. J Pediatrics, in press.
Stephen E. Gitelman, M.D.
2005 Herold KC, Bisikirska B, Gitelman SE, Masharani U, Hagopian W, Donaldson D, Rother K, Diamond B, Harlan D, Bluestone JA. A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 54: 1763-9.
Stephen E. Gitelman, M.D.
2005 Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, Lustig RH, Mathias RS, Portale AA, Miller WL, Gitelman SE. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 352: 1884-1890.
Stephen E. Gitelman, M.D.
2005 Diabetes Prevention Trial – Type 1 Study Group[Gitelman SE—Study Group Member]. Effects of oral insulin in relatives of patients with type 1 diabetes: the Diabetes Prevention Trial-Type 1. Diabetes Care 28: 1068-1076.
Stephen E. Gitelman, M.D.
Chikuma, S., Imboden, J. B. and Bluestone, J.A. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 197:129-135 2003.
Jeff Bluestone, PhD
Belghith, M., Bluestone, J.A., Barriot, S., Garcia, C., Bach, J-F., Chatenoud, L. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nature Medicine 9:1202-8, 2003.
Jeff Bluestone, PhD
Bour-Jordan, H., Grogan, J.L. Tang Q., Auger , J.A., Locksley, R.M., and Bluestone, J.A CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment. Nature Immunol. 4:182-188, 2003.
Jeff Bluestone, PhD
Tang, Q., Henriksen, K.J., Boden, E.K., Tooley, A.J., Subudhi, S.K., Zheng X.X., Strom, T.B., Bluestone J.A. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol 171:3348-52, 2003.
Jeff Bluestone, PhD
 
//